Selective targeting free beta‐2 microglobulin as a promising therapeutic strategy for Alzheimer’s Disease
Specific targeting free β2m using ADEL-Y03 antibody may be a promising approach to developing new therapies for AD without deleterious effects such as downregulating immune function of MHC-I.
Authors
- Yeon‐Seon Mun
- Ha‐Lim Song
- Jun‐Seop Shin (ORCID: https://orcid.org/0000-0001-5142-2818)
- S H Han (ORCID: https://orcid.org/0000-0002-0925-0546)
- Nayoung Kim (ORCID: https://orcid.org/0000-0002-9397-0406)
- Min‐Seok Kim (ORCID: https://orcid.org/0000-0003-3425-882X)
- Seung‐Yong Yoon (ORCID: https://orcid.org/0000-0003-0325-9993)
- Mi‐Hyang Cho
- Dong‐Hou Kim
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.088124
- Citations
- 1
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.25